Vijay Samant

Track

Insider profile

Currently holds a position at Brickell Biotech Inc

Performance

Overall performance
1.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 13% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -49%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Director Brickell Biotech Inc Aug. 31, 2019 -
President, Chief Executive Officer, Director Brickell Biotech Inc Jan. 1, 2014 - Aug. 31, 2019
Director Armata Pharmaceuticals Inc Nov. 5, 2015 - May 9, 2019
Independent Director Horizon Pharmaceutical LLC April 11, 2011 - July 28, 2014
President, Chief Executive Officer, Acting Chief Financial Officer, Director Brickell Biotech Inc April 12, 2013 - Dec. 1, 2013
President, Chief Executive Officer, Director Brickell Biotech Inc Nov. 28, 2000 - April 12, 2013
Vijay Samant's trades of Symbiotec Pharmalab Limited's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
389.06
Quantity 90,963 -16.4%
Value US$1,139,439
Transaction date
Planned sale
Price
0.35
Quantity 11,202 -1.1%
Value US$3,904
Transaction date
Planned sale
Price
0.35
Quantity 48,535 -4.6%
Value US$16,856
Transaction date
Planned sale
Price
0.36
Quantity 75,000 -6.6%
Value US$27,090
Transaction date
Purchase
Price
4.47
Quantity 1,000 +1.6%
Value US$4,470
Transaction date
Planned purchase
Price
4.76
Quantity 1,000 +1.7%
Value US$4,760
Transaction date
Planned purchase
Price
4.64
Quantity 1,000 +1.8%
Value US$4,640
Transaction date
Planned purchase
Price
4.99
Quantity 1,000 +1.8%
Value US$4,990
Transaction date
Planned purchase
Price
5.00
Quantity 1,000 +1.8%
Value US$5,000
Transaction date
Purchase
Price
4.95
Quantity 1,000 +25.0%
Value US$4,950
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-05 2026-09-30
S Sale
99,897
43.19
₹1,880,119 		99,897 43.19 ₹1,880,119
2026-10-05 2026-09-24
S Sale
73,032
189.30
₹530,476 		73,032 189.30 ₹530,476
2016-12-13 2016-12-13
S Sale
90,963 -16.4%
389.06
US$1,139,439 		90,963 -16.4% 389.06 US$1,139,439
2016-06-10 2016-06-09
B Purchase
15,700 +16.2%
4.72
US$74,154 		15,700 +16.2% 4.72 US$74,154
2016-03-03 2016-03-03
PlS Planned sale
5,900 -0.6%
0.37
US$2,199 		5,900 -0.6% 0.37 US$2,199
2016-03-03 2016-03-01
PlS Planned sale
17,600 -1.7%
0.35
US$6,237 		17,600 -1.7% 0.35 US$6,237
2016-01-13 2016-01-12
PlS Planned sale
11,202 -1.1%
0.35
US$3,904 		11,202 -1.1% 0.35 US$3,904
2016-01-13 2016-01-11
PlS Planned sale
48,535 -4.6%
0.35
US$16,856 		48,535 -4.6% 0.35 US$16,856
2016-01-08 2016-01-07
PlS Planned sale
75,000 -6.6%
0.36
US$27,090 		75,000 -6.6% 0.36 US$27,090
2013-01-15 2013-01-11
B Purchase
84,600 +14.8%
0.01
US$846 		84,600 +14.8% 0.01 US$846
2012-01-18 2012-01-13
B Purchase
67,000 +13.0%
0.01
US$670 		67,000 +13.0% 0.01 US$670
2011-01-11 2011-01-07
B Purchase
150,000 +39.0%
0.01
US$1,500 		150,000 +39.0% 0.01 US$1,500
2008-01-07 2008-01-04
B Purchase
25,000 +14.6%
0.01
US$250 		25,000 +14.6% 0.01 US$250
2004-12-01 2004-12-01
B Purchase
1,000 +1.6%
4.47
US$4,470 		1,000 +1.6% 4.47 US$4,470
2004-10-01 2004-10-01
PP Planned purchase
1,000 +1.7%
4.76
US$4,760 		1,000 +1.7% 4.76 US$4,760
2004-08-02 2004-08-02
PP Planned purchase
1,000 +1.8%
4.64
US$4,640 		1,000 +1.8% 4.64 US$4,640
2004-07-19 2004-07-16
PP Planned purchase
1,000 +1.8%
4.99
US$4,990 		1,000 +1.8% 4.99 US$4,990
2004-05-07 2004-05-06
PP Planned purchase
1,000 +1.8%
5.00
US$5,000 		1,000 +1.8% 5.00 US$5,000
2004-01-05 2004-01-02
B Purchase
1,000 +25.0%
4.95
US$4,950 		1,000 +25.0% 4.95 US$4,950